Generic Facility Fee Unlikely To Be Charged Until A Few Months After GDUFA Implementation
By
Derrick Gingery / Email the Author / “The Pink Sheet” DAILY Dec. 19, 2011
Word Count: 951 / Article # 14111219005
Executive Summary
FDA will need a bit of time to develop a comprehensive database of all the facilities that produce active pharmaceutical ingredients and finished dosage forms for the U.S. market as part of the proposed generic drug user fee program.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.